Acro Biomedical Co, LTD 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
OTC.Pink
Acro Biomedical Co., Ltd. reports no revenue since late 2022, significant losses, and a going concern warning, alongside a recent CEO change and challenges in its cordyceps product market.
OTC.Pink
Acro Biomedical Co., Ltd. filed its 2024 annual report, revealing no revenue, significant losses, and substantial doubt about its ability to continue as a going concern.
OTC.Pink
Acro Biomedical Co., Ltd. filed its annual report for 2023, revealing no revenue, substantial net losses, and significant going concern doubts.